Full-length HIV-1 RNA plays a central role in viral replication by serving as the mRNA for essential viral proteins and as the genome packaged into infectious virions. Proper RNA trafficking is required for the functions of RNA and its encoded proteins; however, the mechanism by which HIV-1 RNA is transported within the cytoplasm remains undefined. Full-length HIV-1 RNA transport is further complicated when group-specific antigen (Gag) protein is expressed, because a significant portion of HIV-1 RNA may be transported as Gag-RNA complexes, whose properties could differ greatly from Gag-free RNA. In this report, we visualized HIV-1 RNA and monitored its movement in the cytoplasm by using singlemolecule tracking. We observed that most of the HIV-1 RNA molecules move in a nondirectional, random-walk manner, which does not require an intact cytoskeletal structure, and that the meansquared distance traveled by the RNA increases linearly with time, indicative of diffusive movement. We also observed that a single HIV-1 RNA molecule can move at various speeds when traveling through the cytoplasm, indicating that its movement is strongly affected by the immediate environment. To examine the effect of Gag protein on HIV-1 RNA transport, we analyzed the cytoplasmic HIV-1 RNA movement in the presence of sufficient Gag for virion assembly and found that HIV-1 RNA is still transported by diffusion with mobility similar to the mobility of RNAs unable to express functional Gag. These studies define a major mechanism of HIV-1 gene expression and resolve the long-standing question of how the RNA genome is transported to the assembly site.
HIV-1 | RNA | transport | cytoplasm | diffusion F ull-length HIV-1 RNA has two critical functions in the viral replication cycle (Fig. S1 ): It serves as the viral genome in virions and as the template for the translation of group-specific antigen (Gag) and Gag-Pol polyproteins, which constitute the viral structural proteins and enzymes required for viral replication. HIV-1 RNA must travel to specific subcellular locations to serve its functions. Defects in RNA trafficking or mislocalization in the cytoplasm can affect not only the function of the viral RNA, making it unable to be packaged efficiently (1) , but also the function of the proteins translated from the RNA, such as generating Gag with targeting and assembly defects (2-4). Although these studies highlight the importance of HIV-1 RNA trafficking in viral replication, the mechanism used to transport HIV-1 RNA in the cytoplasm remains undefined.
The transport of cellular mRNA in the cytoplasm can be complex. Some mRNAs are transported in the cytoplasm predominantly by diffusion, whereas other mRNAs are actively transported along the cytoskeleton by motor proteins to specific locations in the cytoplasm (5) (6) (7) (8) (9) (10) . Currently, it is unclear whether HIV-1 RNA uses diffusion and/or motor transport to reach targeted locations. The cytoplasmic transport of HIV-1 RNA can be further complicated by the presence of viral protein components. During the early phase of HIV-1 expression, fulllength RNA is transported in the cytoplasm without the influence of the viral structural protein or enzymes because Gag and Gag-Pol are encoded in the message. Attempts to visualize and follow HIV-1 RNA signals in the cytoplasm without Gag had not been successful (11) . However, a study using total internal reflection fluorescence (TIRF) microscopy to observe the volumes near the glass-cell interface had shown that HIV-1 RNA not encoding Gag can be detected on plasma membrane (12) . After translation of the unspliced RNA, Gag is present in the cytoplasm and can potentially interact with full-length RNA to affect its transport. Gag binds to full-length HIV-1 RNA to allow the specific packaging of the RNA genome into assembling particles. Although Gag-RNA complexes were detected in the cytoplasm in some studies (13) , when and where the Gag-RNA interaction first occurs remain controversial (14, 15) . Recent studies suggest that the Gag-RNA complex is transported in the cytoplasm via endosomal pathways for the assembly of nascent viruses (11, 16) . Although some Gag-RNA complexes were observed to move in a directional manner, inhibition of the endosomal pathway does not reduce infectious virus production (11, 16, 17) , which is not consistent with this suggestion. Compounded with the inability to visualize and follow cytoplasmic HIV-1 RNA signals in the absence of Gag (11), many basic questions regarding HIV-1 RNA trafficking remain unanswered.
We previously described a system that can efficiently label and detect HIV-1 RNA in viral particles with single-RNA sensitivity (18) . Briefly, HIV-1 genomes were engineered to contain binding sites for BglG, an Escherichia coli antitermination protein Significance HIV-1 full-length RNA must go to specific subcellular compartments to carry out its functions as a template for translation of structural and enzymatic proteins and as the genetic material for new virions. RNA mislocalization can affect the functions of the RNA and its encoded proteins, causing defects in viral replication. Currently, little is known about how HIV-1 RNA is transported in the cytoplasm. Here, we demonstrate that HIV-1 full-length RNAs use diffusion as the major mechanism for cytoplasmic transport in the absence of viral group-specific antigen (Gag) proteins and even in the presence of sufficient Gag proteins for virus assembly, indicating that Gag does not alter the RNA transport mechanism. These studies provide insights into mechanisms essential to viral replication. (19) ; because the binding sites are located in pol, only full-length viral RNAs contain these sequences. These full-length HIV-1 RNAs are functional; they can express encoded Gag protein and can be efficiently packaged into particles (18) . When such HIV-1 RNAs are coexpressed with a modified BglG fused to a fluorescent protein, through binding of the fusion protein to viral RNA, fluorescent signals are efficiently detected in the viral particles. Furthermore, the detected fluorescent signals are specific, because such signals are not detected in viral particles containing HIV-1 RNA molecules lacking the BglG-binding sites (18) .
In this report, we sought to determine the major mechanism that transports HIV-1 RNA in the cytoplasm. By tagging HIV-1 RNA with a modified BglG protein fused to YFP (Bgl-YFP), we performed single-molecule tracking of HIV-1 RNA and found that most of the HIV-1 RNA moves dynamically in the cytoplasm in a nondirectional manner that is characteristic of diffusive movement. Furthermore, an intact cytoskeletal structure is not required for RNA movement. Although determining where Gag and RNA first interact is not our experimental goal, the presence of Gag may affect viral RNA transport. To address this issue, we studied HIV-1 RNA transport in cells that expressed sufficient levels of Gag for virus assembly and found that most RNAs are transported by diffusion. Finally, we tested the hypothesis that endocytosed viral particles contribute to the previously observed directional cotrafficking of Gag-RNA signals.
Our results demonstrate that the directional transport of colocalized Gag-RNA signals has behavior similar to the behavior of the endocytosed particles or assembling complexes, indicating these signals are inbound endocytosed particles rather than outbound complexes for virus assembly. These results answer fundamental questions of HIV-1 biology and shed light on essential steps in viral replication.
Results
Detecting HIV-1 RNA Signals in Living Cells. To gain a better understanding of HIV-1 RNA transport in the cytoplasm, we visualized HIV-1 RNA in living cells and followed its movement by tagging the RNA with Bgl-YFP (Fig. 1A) . Bgl-YFP contains a nuclear localization signal that directs the protein to the nucleus but can traffic back into the cytoplasm upon binding to HIV-1 RNA containing the BglG-binding sites. We first studied HIV-1 RNA transport in the absence of Gag to avoid the complication of observing Gag-RNA complexes. For this purpose, we introduced a point mutation that changes the translation initiation codon of Gag from AUG to AAG to abolish Gag translation (1-AAG). The AAG mutation does not affect functions of the viral genome other than abolishing Gag translation, because RNA containing this mutation could be packaged into viral particles and undergo one round of replication efficiently when viral proteins were supplemented in trans (20) .
We visualized HIV-1 RNA using high-speed, wide-field fluorescent microscopy and observed puncta of YFP signals in the cytoplasm of HeLa cells when 1-AAG RNA and Bgl-YFP were coexpressed (Fig. 1) . The cytoplasmic YFP puncta were specific to Bgl-YFP-tagged HIV-1 RNA, because such signals were absent when only Bgl-YFP was expressed or when Bgl-YFP was coexpressed with an HIV-1 RNA that did not contain BglG recognition sites. Furthermore, the intensities of the RNA puncta were similar to the RNA signals from HIV-1 particles imaged under the same conditions (Fig. S2) , suggesting that each punctum represents the signal from one or two copies of viral RNA.
Analyzing HIV-1 RNA Movement by Single-Molecule Tracking. Most of the cytoplasmic HIV-1 RNAs that we observed had dynamic motion and moved rapidly in a nondirectional, random-walk manner ( Fig. 1 B-D and Movie S1). To analyze their movement, we performed single-molecule tracking to follow individual distinct RNA signals through subsequent frames of captured images. Fig. 1B shows an example of a cell with a maximum projection of YFP signals from 14 frames. To illustrate the tracking of the RNA signals, a region of the cell was selected (white box in Fig. 1B) , and each of the 14 frames of this region, along with the maximum projection of the 14 frames of YFP signals, is shown in Fig. 1D and Movie S2. Three distinct RNA signals in each frame are highlighted by red, blue, and green circles, and the accumulated spatial movements of these RNA signals are shown in Fig. 1C ; the RNA signals indicated by red and blue circles moved in a nondirectional manner, whereas the RNA signals indicated by green circles may have moved in a directional manner. A visual inspection of the entire cell (Fig. 1B and Movie S1) revealed that most of the RNA signals engaged in random-walk movement and did not travel in a directional manner. Using the dynamic information obtained from subsequent frames of the movies, we calculated the distance the RNA signals migrated with time. We also determined the persistence index of the RNA signals, which indicates whether a signal is moving in a given direction; for example, if a signal travels in a straight line toward the same direction, the persistence index is 1.
We analyzed 5,077 RNA signals from 11 cells by single-molecule tracking; the vast majority of the RNA signals (>99%) moved in a nondirectional manner. Five examples of RNA signals moving in a random-walk manner are shown in Fig. 2A (I-V) and Movie S3. The lengths of time for which these RNA tracks remained in the observation volume are indicated in seconds in Fig. 2A . The movement of these RNA signals is shown in Fig. 2A (Left) using color-coded tracks: The beginning frames of the signals are shown in red, the last frames are shown in yellow, and the frames between are shown as a gradation of red to yellow. The maximum projections of these RNA signals are shown in Fig. 2A (Right) for comparison. The nondirectional movement of these HIV-1 RNAs is consistent with diffusion as the major mechanism for transport; the movement of some of the tracks was limited part of the time, suggesting possible restriction by subcellular structures.
To test the mechanism that transports 1-AAG RNA further, we examined the mean square displacement (MSD) of the RNA tracks, which measures the mean of squared distance a particle travels within a given time. In the case of diffusion, the MSD value increases with time in a linear manner. We calculated the ensemble MSDs (Materials and Methods) over four steps of the 1-AAG RNA tracks and found a linear relationship between MSD values and time (R 2 > 0.9), supporting the conclusion that diffusion is the major mechanism for RNA transport. We also calculated a diffusion coefficient (0.09 μm 2 ·s −1 ) based on the ensemble MSD measurements.
Of the 5,077 RNA tracks examined, two RNA signals appeared to exhibit directional movement for an extended number of frames with a persistence index of ≥0.7. The first example has 31 frames of directional movement; of these 31 frames, 14 are shown as the green track in Fig. 1 C and D. The second example is shown in the last set of panels in Fig. 2A (VI) and Movie S3. During the observation time, this signal moved in a directional manner for 48 frames (2.0 s) and then switched to random-walk movement for an additional 181 frames (7.6 s).
It is possible for a molecule to travel in the same direction for some steps during nondirectional movement. To determine whether the two RNA signals that appeared to travel directionally were likely to be generated by chance during diffusive random-walk movement, we performed simulation studies using the measured mobility characteristics of 1-AAG RNA (described in the next section) to model the behavior of 5,077 RNA tracks (the number of observed tracks in the study). We compared the observed 1-AAG RNA behavior with the average of 100 simulation studies (Fig. S3 ). These analyses suggest that the two tracks (green track in Fig. 1 and track shown in Fig. 2A , V) displayed directional movement beyond what would be predicted from diffusion and were unlikely to be generated by a random-walk mechanism. Because only two of 5,077 tracks exhibited directional movement, these results further support the idea that HIV-1 RNA uses diffusion as the major mechanism for transport.
Analyzing the Mobility of HIV-1 RNA. The ensemble MSD analysis reveals the average behavior of the RNA tracks but does not provide insights into whether there is more than one mobility behavior in the population. To understand the mobility of HIV-1 RNA better, we calculated the jump distance traveled by each RNA track from one frame to the next, which is the distance traveled within 42 ms: A total of 101,200 one-step jump distances were obtained from the 5,077 RNA tracks. The distribution of Data were binned (40-nm bin size) and normalized to the bin that contained the most events, which was set to 100. x axis, onestep jump distance (displacement); y axis, frequency in arbitrary units (a.u.). The distribution was fitted with a three-component model using a constant diffusion coefficient (D1 = 0.01 μm 2 ·s −1 ) to represent the stagnant fraction (or mobility under the detection limit in our system) ( these one-step jump distances is shown in Fig. 2B ; the jump distance (displacement) is displayed in the x axis, and the frequency is displayed in the y axis, with the frequency of distance that was most often traveled set to 100. The distribution of the one-step jump distances was too heterogeneous to fit the assumption of a single diffusion coefficient. To describe the HIV-1 RNA mobility better, we performed a curve-fitting function and found that the distribution of the one-step jump distances was consistent with the assumption that 1-AAG RNA could assume three mobility fractions-stagnant, intermediate, and fast, which occupied 3.3%, 62.5%, and 34.2% of the observed jump distances, respectively. The stagnant fraction is defined by the localization precision of our system, which was 40 nm, and yielded a diffusion coefficient of 0.01 μm , respectively. We envision two possible scenarios that can generate different mobility fractions in HIV-1 RNA. It is possible that there are distinct classes of RNA that move with different speeds in the cytoplasm. Alternatively, HIV-1 RNA may change mobility as it travels through the cytoplasm, and a single RNA can exhibit different mobility fractions at various times. We performed an analysis as described by Kubitscheck and coworkers (21) to distinguish between these two possibilities. If there are distinct classes of HIV-1 RNA moving at different speeds, we should be able to isolate a fast-moving RNA class by extracting RNA tracks that, in at least one of the steps, have a very large one-step jump distance. For this purpose, we identified 3,532 tracks that contained at least one jump at a distance >250 nm; according to our curve-fitting results, less than 0.5% of the intermediate-speed fraction (green line in Fig. 2B ) would have traveled at this distance. There were a total of 82,044 steps among the 3,532 tracks; the distribution of the one-step jump distances (green line in Fig.  2C and red line in Fig. S5A ) was similar to the distribution of the one-step jump distances of the total population (red line in Fig. 2 B and C). These results suggest that (i) HIV-1 RNAs that are capable of moving fast also have steps in which they move more slowly and (ii) the proportions of three diffusion coefficient fractions (D1 = 2.8%, D2 = 56.8%, and D3 = 40.4%; Fig. S5A ) were similar to the distribution of the total population shown in Fig. 2B . We also examined whether signals that moved more slowly at some time points were capable of moving fast at other times; to this end, we extracted 962 tracks that contained a jump distance of ≤40 nm in at least one step (our localization precision; Materials and Methods). There were 23,721 steps in these 962 tracks, and the distribution of the one-step jump distances (blue line in Fig. 2C and red line in Fig. S5B ) revealed that these RNA signals could also move at intermediate or fast mobility. Together, these analyses revealed that individual HIV-1 RNAs could change their mobility while traveling through the cytoplasm. We hypothesize that the immediate cytoplasmic environment affects the RNA mobility (Discussion).
Effects of Disturbing Actin and Microtubules on HIV-1 RNA Trafficking.
The directional movement in the cytoplasm relies on the motor and cytoskeletal structure; hence, disrupting the cytoskeletal structure hinders motor-based directional movement. To examine HIV-1 RNA transport in the cytoplasm further, we assessed whether disrupting the cytoskeletal structure could affect the mobility of HIV-1 RNA in cells. For this purpose, we treated cells with cytochalasin-D or nocodazole to depolymerize the actin or microtubule network, respectively. To ensure the effectiveness of these treatments, we transfected into HeLa cells a plasmid encoding actin tagged with fluorescent protein mCherry (mCherry-actin) or tubulin tagged with YFP (YFPtubulin); 24 h later, we treated the cells with cytochalasin-D (final concentration of 10 μg/mL) or nocodazole (final concentration of 10 μg/mL). Our results showed that treating cells with cytochalasin-D or nocodazole for 60 min effectively disrupted the actin or microtubule filaments, respectively (Fig. S6) . We then used the aforementioned conditions to examine the movement of 1-AAG RNA 60-90 min posttreatment. We followed 2,891 RNA tracks with cytochalasin-D treatment and 2,441 RNA tracks with nocodazole treatment, from which 62,418 and 28,476 one-step jump distances were calculated, respectively (Fig. 3) . We found that the overall HIV-1 RNA mobility was not changed upon cytochalasin-D treatment ( Fig. 3 A and C) , indicating an intact actin structure is not required for HIV-1 RNA transport. However, nocodazole treatment appeared to increase HIV-1 RNA mobility and shifted the distributions of the stagnant, intermediate, and fast fractions (Fig. 3 B and C) . Additionally, there were generally fewer steps per RNA track observed in nocodazole-treated samples: 28,476 steps for 2,441 RNA tracks from nocodazole-treated cells vs. 101,200 steps for 5,077 RNA tracks for cells without drug treatment (P < 0.001, χ 2 test). The decrease in the observed steps was consistent with faster mobility, because a faster moving RNA would be expected to stay in the observation volume for a shorter duration. A possible explanation is that disrupting the microtubules created a less organized subcellular structure, thereby promoting the diffusion of HIV-1 RNA in the cytoplasm. These results revealed that 1-AAG RNA movement was not hindered by cytochalasin-D or nocodazole treatment. Therefore, disturbing the actin or microtubule structure in the cells did not stall the mobility of HIV-1 RNA, which is consistent with RNA using diffusion, and not motor-based transport, as the major transport mechanism.
Effects of Gag Expression on HIV-1 RNA Trafficking. Interactions between viral protein Gag and full-length RNA may potentially change the mechanism by which viral RNA is transported. To examine the effects of HIV-1 Gag on viral RNA trafficking, we studied HIV-1 RNA and Gag movement simultaneously. For this purpose, we used two HIV-1 constructs that are structurally similar to 1-AAG but contained an AUG at the Gag translational start codon (Fig. 4A) ; one construct expressed a Gag tagged with mCherry (1-GagmCherry-BSL), and the other construct expressed a Gag without the mCherry (1-Gag-BSL). We transfected these two HIV-1 constructs at equal weight ratios into cells, along with plasmid Bgl-YFP, and then monitored the appearance of RNA and Gag signals as well as their movements in the cytoplasm. We always observed that the RNA signals appeared in the cytoplasm first before the detection of Gag signals and that the numbers of both signals increased with time.
Although the increase in RNA and Gag signals occurs in a continuous manner, for discussion purposes, we describe this process in stages. Early after transfection (often ∼9-12 h posttransfection), we observed cytoplasmic RNA signals (YFP puncta) before the Gag-mCherry signals become detectable, and in some cells, we observed both cytoplasmic YFP puncta and diffused Gag-mCherry signals. At this time, HIV-1 RNA signals moved in a nondirectional, random-walk manner, similar to the manner of 1-AAG RNAs. Using the persistence index analyses, we found that one of the 2,539 tracks displayed directional movement. However, it is possible that in these cells, the Gag level was insufficient to affect RNA transport. To address this possibility, we analyzed the movement of HIV-1 RNA in cells that contained assembling Gag particles.
At a later time point, generally ∼13 h posttransfection, among the diffused mCherry signals, some Gag-mCherry puncta were observed near the periphery of the cells (Fig. 4B, Left) . These Gag puncta were often colocalized with the RNA signals (Fig.  4B, Right) ; additionally, their locations (near or at the plasma membrane), lack of mobility, and Gag signal intensities were consistent with the intensities of assembling complexes. Despite a few immobile RNA signals that colocalized with Gag puncta, most of the HIV-1 RNA signals moved dynamically in the cytoplasm of these cells (Fig. 4B , Middle and Movie S4). The close-up views in Fig. 4B (Insets) display the maximum intensity projection of 50 consecutive frames that show the accumulated movement of signals over 2 s. As shown in Fig. 4B (Middle and Left Insets), the two RNA signals colocalizing with Gag puncta (indicated by white arrows) did not have significant movement, whereas other RNA signals that did not colocalize with Gag puncta exhibited detectable movement. We studied the movement of HIV-1 RNAs that were not colocalized with Gag puncta in these cells and analyzed 1,534 RNA tracks from four cells. A total of 26,554 one-step jump distances were generated, which contain 5.1%, 51.3%, and 43.6% of the stagnant, intermediate, and fast populations, respectively, and their distribution is shown in Fig. 4C . Thus, the one-step jump distance of 1-Gag-BSL RNA is similar to the one-step jump distance of 1-AAG RNA (Fig.  4D) . We also analyzed the proportion of 1-Gag-BSL RNA tracks that displayed directional movement, using the same persistence index scanning method described in the 1-AAG RNA analyses and found that none of the 1,534 tracks displayed directional movement that fit the aforementioned criteria. We further analyzed these results by performing an MSD analysis and found that the MSD value exhibits a linear relationship with time (R 2 > 0.9), which further confirmed that diffusion was used as the major transport mechanism. The diffusion coefficient calculated from ensemble MSD values is 0.11 μm 2 ·s −1 , similar to the diffusion coefficient of 1-AAG RNA. Therefore, even when Gag proteins were expressed at levels sufficient for viral particle assembly, HIV-1 RNA moved dynamically in a random-walk manner in the cytoplasm, indicating that diffusion is the major mechanism for RNA transport.
Mobility of the HIV-1 RNA-Encoding Mutant Gag Lacking the
Nucleocapsid Domain. The mobility of 1-AAG RNA and 1-Gag-BSL RNA is not significantly different, suggesting that the presence of Gag does not affect HIV-1 RNA mobility. It has been demonstrated that HIV-1 may contain cis-acting sequences that direct translation using the AUG codon located in the capsid domain of the gag gene (22) . Hence, 1-AAG RNA may express truncated Gag proteins containing the nucleocapsid domain, which can potentially bind HIV-1 RNA and alter its mobility. To address this possibility, we determined the mobility of 1-Gag leucine zipper (LZ)-BSL RNA (Fig. 4E) . Two constructs were used, 1-GagLZmCherry-BSL and 1-GagLZ-BSL, that contain the same general structures as 1-GagmCherry-BSL and 1-Gag-BSL, respectively, except for the replacement of their nucleocapsid domains with an LZ motif (23) . It is well established that this mutation abolishes the ability of Gag to package HIV-1 RNA (24, 25) ; hence, GagLZ proteins should not bind HIV-1 RNA and alter its transport. As shown in the representative images in Fig. S7 and Movie S5, the GagLZ-mCherry puncta do not colocalize with RNA signals, which is expected based on their inability to package viral RNA. We tracked 1,887 RNA trajectories from four cells; none of the tracks displayed directional movements. From these trajectories, 28,368 one-step jump distances were generated; their distribution (summarized in Fig. 4F ) is similar to the distribution of 1-AAG RNA (Fig. 4G) . We also performed MSD analyses and showed that the MSD values increase linearly with time (R 2 > 0.9) and the ensemble diffusion coefficient is 0.09 μm , similar to the diffusion coefficients of 1-AAG and 1-Gag-BSL. These results confirmed that there is little difference between the mobility of HIV-1 RNAs, regardless of whether they are in the presence of Gag proteins that can bind HIV-1 RNA.
Determining the Conditions That Lead to Enhanced Directional
Gag-RNA Movement. Previous literature suggests that HIV-1 RNA is transported by the endosomal pathway (11, 16) . In a report by Molle et al. (11) , directional HIV-1 RNA transport was observed in the presence of Gag. In our studies, although a few RNA tracks displayed directional movement, the majority of HIV-1 RNAs moved in a nondirectional manner, both in the presence and the absence of Gag. To investigate these apparent differences further, we examined whether we could observe frequent directional RNA movement in our system and, if so, what experimental conditions are required for such an observation. We found that several hours after the first appearance of the colocalized RNA-Gag puncta, starting from 17 h and often after 20 h posttransfection, some Gag-RNA signals appeared to move in a directional manner. These directional-moving complexes were more frequently observed near the bottom of the cells. An example of such Gag-RNA signals near the bottom of the cells is shown in Fig. 5A and Movie S6. The close-up views in Fig. 5A (Insets) are the maximum projection of 50 consecutive frames, in which five tracks (white arrows) with both YFP and mCherry signals exhibited apparent directional movement. We have analyzed 24 RNA tracks that exhibited directional movement; 23 of these RNA tracks were associated with a strong Gag-mCherry signal. Furthermore, the intensities of the Gag-mCherry signals were close to the intensities from fully assembled HIV-1 particles (Fig. S8A) . Many of these YFP-mCherry double-positive signals moved in complex trajectories with frequent pauses and a moving speed of 1-3 μm·s −1 (an example is shown in Fig. S8 B and C), reminiscent of those molecules transported by microtubules (26, 27) . We noted that even when directional HIV-1 RNA movements can be easily observed, most HIV-1 RNAs still move in a nondirectional manner. To illustrate this point, we performed persistence index analyses of 1,122 RNA tracks from four cells and found that eight RNA tracks displayed directional movement. Although there was more directional movement than from 1-AAG RNA, only a small percentage of the RNA tracks in these cells (∼0.7%) displayed directional movement. Hence, most of the HIV-1 RNA still uses diffusion for transport.
Directional Gag Movement Is Consistent with Endocytosed HIV-1
Particles. It has been reported that assembled HIV particles can be internalized by endocytosis and transport to lysosomes to be destroyed (17) . We hypothesize that the observed directional Gag/RNA movements are assembled HIV-1 particles/complexes internalized by endocytosis for the following reasons. First, these signals were observed after abundant particle assembly, and, second, most of the RNAs we observed that traveled in a directional manner are associated with strong Gag signals with intensities close to the intensities of viral particles. To test this hypothesis, we coexpressed Gag-mCherry with a late endosome marker, Rab7-YFP, and simultaneously captured the images of Gag-mCherry and Rab7-YFP. Most of the Gag puncta were fairly immobile, consistent with assembling/assembled complexes. However, 17-24 h posttransfection, we observed that some Gag-mCherry puncta moved in a directional manner; many of the directional-moving Gag puncta were colocalized with Rab7-YFP signals (Fig. 5B,  Upper) . Furthermore, the comigrating Gag-Rab7 signals displayed directional but complex movement reminiscent of endosomal transport [ Fig. 5B , Top (Insets) and Movie S7]. To test whether the directional movement is dependent on the intact microtubule structure, we treated the cells with nocodazole and found that this drug treatment abolished the directional mobility of Gag-mCherry and Rab7-YFP puncta (Fig. 5B , Bottom and Movie S8).
To investigate the nature of the directional-moving Gag-RNA complexes further, we examined the effect of inhibiting endocytosis on the behavior of HIV-1 RNA and Gag signals. For this purpose, we used a dominant-negative K44A dynamin mutant (K44A HA-dynamin) that has been shown to inhibit clathrinmediated endocytosis (28) . We coexpressed HIV-1 constructs with either HA-tagged WT dynamin or HA-tagged dynamin containing the K44A mutation. Coexpressing WT dynamin did not have observable effects on the directional cotrafficking of Gag-RNA signals, whereas such directional Gag-RNA movement was drastically inhibited by the presence of K44A dynamin (Fig. 5C , Top and Bottom and Movies S9 and S10, respectively). The results from the persistence index analyses are shown in Fig.  5D ; 13 of 2,643 RNA tracks from four cells transfected with WT dynamin displayed directional movement (0.5%), whereas two of 5,394 RNA tracks from five cells transfected with K44A dynamin had directional movement (0.04%). Hence, inhibiting endocytosis drastically reduced the proportion of directional-moving Gag-RNA complexes. Taken together, these results are consistent with the hypothesis that the observed Gag-associated directionalmoving RNA molecules are assembled HIV-1 particles/complexes internalized by endocytosis.
Discussion
In eukaryotic cells, after exiting the nucleus, an mRNA needs to be transported to its destination in the cytoplasm. Hence, RNA transport is an essential part of gene expression. In this report, we sought to determine the mechanism by which HIV-1 fulllength RNA is transported in the cytoplasm. Several lines of evidence showed that diffusion is the major mechanism for cytoplasmic HIV-1 RNA transport. First, HIV-1 RNA movement lacks directionality. Second, a linear relationship exists between time and the mean-squared distance traveled by the RNA, which is indicative of diffusive movement. Finally, an intact cytoskeletal structure, which is required for active transport by motor proteins, is not needed for HIV-1 RNA movement in the cytoplasm. Although motor-based transport does not play a critical role in the transport of nascent HIV-1 RNA, it has been reported to mediate the transfer of the incoming viruses, first by Hope and coworkers (29) and then by others (summarized in ref. 30) .
Although this study is not focused on defining the location at which Gag and RNA initiate interaction, the presence of Gag could influence HIV-1 RNA transport. Indeed, how the RNA genome is transported to the virus assembly site has been a longstanding question in HIV-1 research. It was speculated that Gag escorts RNA to the assembly site (14) , and some reports suggest that the Gag-RNA complex travels in the cytoplasm by motorbased transport (11, 16) , which is supported by the previously observed directional transport of such complexes. We have shown that the observed directional-cotrafficked Gag-RNA complexes are mostly, if not entirely, contributed by endocytosed particles for the following reasons. First, directional-transported complexes were observed at a much later time point, after the production of many viral particles; if such complexes are used for transporting HIV-1 RNA required for virus assembly, they should appear at an earlier time before particle formation. Second, the intensity of the Gag signals in these complexes is close to the intensity of the viral particles, which is not consistent with our current understanding that assembly mostly occurs at the membrane. Studies of HIV-1 assembly using TIRF microscopy revealed that Gag signals accumulate with time (12, 31, 32) , indicating that the gradual process of Gag multimerization occurs at the plasma membrane, rather than an entire complex appearing on the plasma membrane. Third, inhibition of endocytosis abolished the observed increased directional transport. Hence, these Gag-RNA signals are mostly inbound endocytic particles.
Our studies indicate that the directionally transported Gag-RNA complexes do not play a significant role in virus assembly; however, this conclusion does not eliminate the possible cytoplasmic interactions between Gag and HIV-1 RNA, and the possible effects of Gag on HIV-1 RNA cytoplasmic transport. HIV-1 RNA is mainly transported by diffusion regardless of the presence of Gag. We have analyzed the movements of three HIV-1 RNAs that differ in their Gag expression: 1-AAG RNA, which does not translate full-length Gag; 1-Gag-BSL RNA, which expresses a WT Gag; and 1-GagLZ-BSL RNA, which expresses a mutant Gag that does not package HIV-1 RNA. We found that all three RNAs have similar mobility, indicating that Gag does not have a significant impact on the overall mobility of the cytoplasmic HIV-1 RNA. This conclusion indicates that HIV-1 RNA does not form very large complexes with Gag in the cytoplasm. Furthermore, even when there are sufficient Gag proteins for virus assembly (Fig. 4) , we did not observe cotrafficking of viral RNA with Gag, suggesting that only a few copies of Gag, if any, are bound to HIV-1 RNA. This observation is consistent with the results from a previous assembly study using TIRF microscopy, in which the viral RNA signal was detected before the Gag signal (12) . Similar to the limitation of the TIRF studies, our study also has a limited ability to detect very low numbers of Gag molecules. Hence, it remains possible that a few copies of Gag protein are bound to HIV-1 RNA; if so, how would such an association affect HIV-1 RNA mobility? The molecular mass of one HIV-1 RNA used in our study is ∼35-fold larger than the molecular mass of one Gag protein. Because the relationship between molecular mass and diffusion is cubed, a twofold difference in mass will result in a 26% difference in mobility. Furthermore, most cytoplasmic mRNAs travel as ribonucleoprotein complexes (RNPs); it is unclear whether Gag binding affects the contents of the other proteins of the RNPs. Hence, even if the RNAs are associated with a few molecules of Gag proteins, their mobility is unlikely to be significantly different from the mobility of RNAs not bound with Gag.
Although there are ample biochemical studies of various RNAs, very few RNA species have been studied at the singlemolecule level in living mammalian cells. The best-studied model system is the transport of mouse β-actin RNA and reporter RNAs containing β-actin sequences. However, HIV-1 RNA is distinct from mouse β-actin and related reporter RNAs in several aspects: HIV-1 RNA is longer, contains introns, and enters the cytoplasm via CRM1-dependent export pathways. Furthermore, mouse β-actin RNA has a "zipcode" sequence in the 3′ UTR region that interacts with zipcode-binding protein to direct motor-based transport and RNA targeting (33) (34) (35) (36) (37) ; such an interaction has not been found in HIV-1 RNA. Although mouse β-actin RNA is transported in the cytoplasm largely by diffusion, it also undergoes motor-based transport directed by the zipcode element, at a frequency that appears to be much higher than the frequency of HIV-1 RNA (6). Recent studies of mouse β-actin and related reporter RNAs demonstrated diffusion rates of 0.09-0.74 μm 2 ·s −1 (8, 38) in the cytoplasm. Our measurement indicates that most of the HIV-1 RNAs diffuse in the cytoplasm at 0.07-0.3 μm 2 ·s −1 (Fig. 2B) , which is similar to the diffusion rate of mouse β-actin RNA. The HIV-1 RNA we used in this study is ∼twofold longer than the aforementioned actin RNAs, which is 3.3 kb; if one projects the diffusion rate based on the RNA mass, then a 26% difference in diffusion rates is expected. Hence, the HIV-1 RNA diffusion rate is in the same range as the diffusion rates of the actin RNAs. An RNA gradient from the perinuclear region to the rest of the cytoplasm was observed in a recent study of mouse β-actin RNA (5). However, based on our movies and images, HIV-1 RNAs were generally well dispersed throughout the cytoplasm, and obvious gradients or concentrations of HIV-1 RNA were not evident in specific cytoplasmic regions. These results suggest that diffusion is an effective mechanism for distributing HIV-1 RNA through the cytoplasm.
We have observed that HIV-1 RNA does not travel at a constant mobility in the cytoplasm; rather, the same RNA can move at different mobilities (Fig. 2) . Such discontinuous movement was previously observed in another study, albeit in the nucleus (21) . The cytoplasm of living cells is a dynamic yet highly crowded and structured fluid (39, 40) . Macromolecular diffusion in such environments could be restricted by interacting with other structures, molecular crowding, or physical obstacles from cytoskeletal and membrane structures. We hypothesize that HIV-1 RNA movement in the cytoplasm was at least partially restricted by physical obstacles in the microtubule structures, because disrupting microtubules increased the fraction of RNA with fast mobility. Such an effect is probably size-dependent, because a previous study did not reveal any effects of microtubule disruption on the mobility of smaller mRNAs in the cytoplasm (5) . The discontinuity and heterogeneity of HIV-1 RNA movement in the cytoplasm make it difficult to estimate the specific time in which a given HIV-1 RNA will travel to the plasma membrane after exiting the nucleus. If HIV-1 RNA traveled in a directional manner at the speed we observed for the two directional tracks at 2-3 μm·s −1 , it would be able to reach the membrane in seconds. However, because the movement of the HIV-1 RNA is nondirectional, the time required for this targeting is far greater. Using the diffusion coefficient of 0.09 μm 2 ·s −1
, we can project a time of ∼20 min for the RNA to reach 20 μm; an estimate of the distance from the nuclear membrane to the plasma membrane is 5-20 μm in a mammalian cell, such as a HeLa cell. However, human T cells generally have a diameter close to 10 μm (41); given the small cytoplasmic volume of these cells, HIV-1 RNA can probably reach the plasma membrane very rapidly using diffusion as a transport mechanism.
Macromolecular trafficking is an important regulatory step of gene expression. Intense efforts to study HIV-1 transcription revealed intricate regulatory processes in the step of RNA synthesis. Similarly, multiple host factors have been identified that affect the nuclear export of HIV-1 RNA. In comparison, little is known about the cytoplasmic transport of HIV-1 RNA. In this report, we have defined the transport mechanism; however, many aspects of the RNA trafficking remain unknown. For example, how do RNA trafficking errors occur, and what causes the defective nature of the Gag protein translated from such RNA (2-4)? We believe that the tools and methods described in this report can help solve these important questions in the future. Better understanding of these issues advances not only our understanding of HIV-1 biology but also intricate aspects of gene expression regulation in human cells.
Materials and Methods
Plasmids, Cell Culture, Transfection, and Viral Particle Preparation. Plasmids 1-GagCeFP-BSL and 1-Gag-BSL have been described previously (18) . Plasmid 1-AAG was generated by mutating the Gag translation start codon in 1-Gag-BSL to AAG by replacing an AatII-to-SphI fragment from pH0-AAG (20); 1-GagmCherry-BSL was generated by replacing the cefp gene in 1-GagCeFP-BSL with mCherry gene. Plasmids 1-GagLZ-BSL and 1-GagLZmCherry-BSL were generated by replacing a DNA fragment, including the nucleocapsid domain, with a DNA fragment containing an LZ motif (23) from pRB3229 (a kind gift from Robert Gorelick, Leidos Biomedical Research, Inc). Plasmid pBgl-YFP was constructed by replacing the MS2 coat protein sequence of pMS2-YFP (6) with the N-terminal RNA-binding domain of BglG protein (18) . Plasmid Rab7-YFP was kindly provided by Eric Freed (National Cancer Institute) and plasmids expressing the HA-tagged WT dynamin and mutant K44A dynamin were obtained from Addgene (nos. 34688 and 34681, respectively).
Human HeLa cells were maintained in DMEM supplemented with 10% FCS, penicillin (50 units/mL), and streptomycin (50 μg/mL). All cultured cells were maintained at 37°C with 5% (vol/vol) CO 2 . Transfection was performed with FuGENE HD (Roche) according to the manufacturer's recommendation.
Microscopy, Image Acquisition, and Processing. Epifluorescence microscopy was performed with an inverted Nikon Ti microscope and a 100 × 1.45-N.A. oil objective, using 514-nm and 594-nm lasers for illumination. Digital images were acquired using an Andor iXon3 897 Camera and NIS-Elements software (Nikon) with emission filters of 542/27 nm and 650/75 nm, respectively. HIV-1 RNA movement was followed by acquiring time-lapse images at 23.8 Hz with a 40-ms integration time and ∼2-ms overhead between frames, resulting in an overall 42-ms frame time. Simultaneous dualcolor imaging was performed by using imaging splitter (QV2; Photometrics), and images of separate channels were aligned with an accuracy of a single pixel. Maximum intensity projection, Laplacian of Gaussian filtering, frame averaging, and movie encoding were performed with ImageJ software (NIH).
To determine the stability and signal localization precision of our imaging system, we acquired time-lapse images of immobilized HIV-1 particles labeled with Bgl-YFP under the same conditions as the conditions of our live-cell imaging. Our results showed that our system had a localization precision of 40 nm and did not exhibit significant drift during the observation period (Fig. S3) .
Single-Molecule Tracking and Analysis. Single-molecule tracking was performed with MATLAB (MathWorks) code (site.physics.georgetown.edu/ matlab/) based on the available tracking algorithms (42) , with maximum single-step displacement of three pixels (0.48 μm) and a minimum track length of five consecutive frames. The positions of the diffraction-limited spots in the trajectories were refined with 2D Gaussian fit (43) . MSDs were calculated from positional coordinates as previously described (44) . In free diffusion, the MSDs [r 2 (t)], are linearly related to time (t) and diffusion coefficient (D) by the formula r 2 (t) = 4 Dt. In jump-distance analysis, the probability that a particle starting at a specific position will be encountered within a shell of radius (r) and width (dr) at time (t) from that position is given as p À r, t Á dt = 1 4πDt e −r 2 =4Dt 2πrdr, when starting at the origin. Experimentally, this probability distribution can be approximated by a frequency distribution, which is obtained by counting the jump distances within respective intervals (r, r + dr) traveled by a single RNA during a given time. When a population contains multiple diffusive fractions, the jump-distance distribution cannot be fitted satisfactorily by the above function with a single diffusion coefficient. Such different mobility fractions can be detected and quantified by curve fitting, taking several diffusion terms into account (45) . The one-component fit has a χ 2 value of 29.5; with 2 df, the probability that this fit describes the RNA mobility is P = 0.001. The three-component fit described in Fig. 2B has a χ 2 value of 1.13; with 5 df, the probability that this fit can reasonably describe the observed RNA mobility is P = 0.95.
The persistence index of a track between two points was calculated by dividing the net distance of the track between two points by the total distance, using the formula P index = dðp1, pLÞ
dðpi , pi+1 Þ , where d represents the distance, p1 represents the initial point, and pL represents the last point. A computer program based on MATLAB was generated to simulate free diffusion in two dimensions. Using this program, and based on Gaussian random-walk movement, we generated 100 sets of simulation with the same number of trajectories, trajectory length distribution, and proportion of the three diffusion coefficients as the 1-AAG dataset. To identify potential directional mobility, we scanned the experimental trajectories and 100 sets of simulated trajectories for segments consisting of 10-48 consecutive steps with a persistence index of ≥0.7.
